Omnicell (OMCL) Gains from Investment Securities (2016 - 2026)
Omnicell has reported Gains from Investment Securities over the past 13 years, most recently at $1.8 million for Q4 2025.
- Quarterly Gains from Investment Securities rose 132.11% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Dec 2025, down 89.13% year-over-year, with the annual reading at -$4.1 million for FY2025, 89.13% down from the prior year.
- Gains from Investment Securities was $1.8 million for Q4 2025 at Omnicell, up from -$9.3 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $9.9 million in Q4 2023 and troughed at -$9.3 million in Q3 2025.
- The 5-year median for Gains from Investment Securities is $2.5 million (2022), against an average of $1.8 million.
- Year-over-year, Gains from Investment Securities tumbled 302.02% in 2023 and then surged 1409.42% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $6.1 million in 2021, then increased by 23.48% to $7.6 million in 2022, then skyrocketed by 30.97% to $9.9 million in 2023, then crashed by 157.6% to -$5.7 million in 2024, then surged by 132.11% to $1.8 million in 2025.
- Per Business Quant, the three most recent readings for OMCL's Gains from Investment Securities are $1.8 million (Q4 2025), -$9.3 million (Q3 2025), and $5.0 million (Q2 2025).